TY  - JOUR

T1  - THE COST-EFFECTIVENESS OF ADALIMUMAB (HUMIRA (TM)) IN PATIENTS WITH RHEUMATOID ARTHRITIS: A UK ANALYSIS

JO  - RHEUMATOLOGY

PY  - 2004/04/01

AU  - Bansback N

AU  - Brennan A

AU  - Sengupta N

AU  - Pang F

ED  - 

VL  - 43

SP  - 77

EP  - 77

Y2  - 2024/12/22

ER  -